Metabolic status differentiates Trp53inp2 function in pressure-overload induced heart failure

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Liu, Jianfang
    • Other Affiliation: Renmin Hospital of Wuhan University
  • Liu, Tian
    • Other Affiliation: University of Cincinnati
  • Ren, Shuxun (Vincent)
    • Other Affiliation: DukeNUS Medical School
  • Zhu, Cansheng
    • Other Affiliation: University of Cincinnati
  • Bouso, Eyad
    • Other Affiliation: University of Cincinnati
  • Mamlouk, Samir
    • Other Affiliation: University of Cincinnati
  • Rau, Christoph D.
    • Affiliation: School of Medicine, Department of Genetics
  • Wang, Yibin
    • Other Affiliation: DukeNUS Medical School
  • Gao, Chen
    • Other Affiliation: University of Cincinnati
Abstract
  • Cardiometabolic disorders encompass a broad range of cardiovascular complications associated with metabolic dysfunction. These conditions have an increasing share in the health burden worldwide due to worsening endemic of hypertension, obesity, and diabetes. Previous studies have identified Tumor Protein p53-inducible Nuclear Protein 2 (Trp53inp2) as a molecular link between hyperglycemia and cardiac hypertrophy. However, its role in cardiac pathology has never been determined in vivo. In this study, we generated a cardiac specific knockout model of Trp53inp2 (Trp53inp2-cKO) and investigated the impact of Trp53inp2 inactivation on the pathogenesis of heart failure under mechanic or/and metabolic stresses. Based on echocardiography assessment, inactivation of Trp53inp2 in heart led to accelerated onset of HFrEF in response to pressure-overload, with significantly reduced ejection fraction and elevated heart failure marker genes comparing to the control mice. In contrast, inactivation of Trp53inp2 ameliorated cardiac dysfunction induced by combined stresses of high fat diet and moderate pressure overload (Cardiometabolic Disorder Model). Moreover, Trp53inp2 inactivation led to reduced expression of glucose metabolism genes in lean, pressure-overloaded hearts. However, the same set of genes were significantly induced in the Trp53inp2-cKO hearts under both mechanical and metabolic stresses. In summary, we have demonstrated for the first time that cardiomyocyte Trp53inp2 has diametrically differential roles in the pathogenesis of heart failure and glucose regulation under mechanical vs. mechanical plus metabolic stresses. This insight suggests that Trp53inp2 may exacerbate the cardiac dysfunction during pressure overload injury but have a protective effect in cardiac diastolic function in cardiometabolic disease.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
License
  • Attribution 4.0 International
Journal title
  • Frontiers in Cardiovascular Medicine
Journal volume
  • 10
Language
  • English
Version
  • Publisher
ISSN
  • 2297-055X
Publisher
  • Frontiers Media SA

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details fcvm-10-1226586.pdf 2024-01-03 Public Download